SCHEMBL4725825

SCHEMBL4725825

CC(C)(C)OC(=O)C(=COC(F)(F)F)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 1/20 0.42
TDP1 Q9NUW8 2/20 0.39
TSHR P16473 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ABCC9 O60706 2/20 0.38
ABCC8 Q09428 2/20 0.38
KCNJ11 Q14654 2/20 0.38
PDK1 Q15118 2/20 0.38
PDK2 Q15119 2/20 0.38
PDK3 Q15120 2/20 0.38
KCNJ8 Q15842 2/20 0.38
PDK4 Q16654 2/20 0.38
ABCB11 O95342 1/20 0.38
CES1 P23141 3/20 0.37
ELANE P08246 3/20 0.36
KDM4E B2RXH2 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GABRB1 P18505 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4649015 0.80 AKR1C1 (0.48) TSHRALDH1A1CES1KDM4EAKR1C1
SCHEMBL7149428 0.78 CES1 (0.41) TDP1TSHRALDH1A1HSD17B10ABCC9
SCHEMBL28126711 0.76 AKR1C1 (0.58) ALDH1A1KDM4EL3MBTL1AKR1C1LMNA
SCHEMBL28704810 0.74 TDP1 (0.40) AAK1TDP1TSHRALDH1A1HSD17B10
SCHEMBL27572281 0.73 CA12 (0.39) TDP1TSHRALDH1A1HSD17B10AKR1C1
SCHEMBL11128335 0.72 TDP1 (0.53) AAK1TDP1TSHRALDH1A1HSD17B10
SCHEMBL8752596 0.71 CES2 (0.52) TDP1TSHRALDH1A1HSD17B10CES1
SCHEMBL10442833 0.70 TDP1 (0.55) AAK1TDP1TSHRALDH1A1HSD17B10
SCHEMBL10770600 0.70 CES2 (0.50) AAK1TDP1TSHRALDH1A1HSD17B10
SCHEMBL28352417 0.70 CES1 (0.41) TDP1TSHRALDH1A1HSD17B10CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1937640-A2 1,2,3,5-TETRAHYDRO-CYCLOPENTAL[C]QUINOLIN-4-ONE DERIVATIVES AS RXR AGONISTS FOR THE TREATMENT OF DYSLIPIDEMIA, HYPERCHOLESTEROLEMIA AND DIABETES JANSSEN PHARMACEUTICA N.V. (BE) 2008-07-02 EP disclosed
WO-2007041076-A2 1,2,3,5-TETRAHYDRO-CYCLOPENTAL[C]QUINOLIN-4-ONE DERIVATIVES AS RXR AGONISTS FOR THE TREATMENT OF DYSLIPIDEMIA, HYPERCHOLESTEROLEMIA AND DIABETES JANSSEN PHARMACEUTICA N.V. (BE) 2007-04-12 WO disclosed